[1]何 涛a,孔德强a,韩雪飞a,等.缺血性脑卒中患者行颈动脉支架成形术前血清CCR5，SDF-1 mRNA 表达水平与术后支架内再狭窄的相关性研究[J].现代检验医学杂志,2022,37(06):171-176.[doi:10.3969/j.issn.1671-7414.2022.06.033]
　HE Taoa,KONG De-qianga,HAN Xue-feia,et al.Correlation between Serum CCR5, SDF-1 mRNA Expression Levels and Postoperative In-stent Restenosis in Patients with Ischemic Stroke before Carotid Artery Stenting[J].Journal of Modern Laboratory Medicine,2022,37(06):171-176.[doi:10.3969/j.issn.1671-7414.2022.06.033]
点击复制

缺血性脑卒中患者行颈动脉支架成形术前血清CCR5，SDF-1 mRNA 表达水平与术后支架内再狭窄的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年06期
页码:
171-176
栏目:
检验与临床
出版日期:
2022-11-15

文章信息/Info

Title:
Correlation between Serum CCR5, SDF-1 mRNA Expression Levels and Postoperative In-stent Restenosis in Patients with Ischemic Stroke before Carotid Artery Stenting
文章编号:
1671-7414(2022)06-171-06
作者:
何 涛a; 孔德强a; 韩雪飞a; 索志超b; 高倩兰a; 吕金梅a
(廊坊市人民医院a. 神经内科；b. 检验科，河北廊坊 065000)
Author(s):
HE Taoa;  KONG De-qianga;  HAN Xue-feia;  SUO Zhi-chaob;  GAO Qian-lana;  L? Jin-meia
(a. Department of Neurology；b. Department of Clinical Laboratory, Langfang People’s Hospital, Hebei Langfang 065000, China)
关键词:
缺血性脑卒中; 趋化因子受体5; 基质细胞衍生因子-1; 颈动脉支架成形术; 支架内再狭窄
分类号:
R743.3；R392.11
DOI:
10.3969/j.issn.1671-7414.2022.06.033
文献标志码:
A
摘要:
目的 分析术前血清趋化因子受体5(chemokine receptor 5，CCR5)、基质细胞衍生因子-1(stromal cellderivedfactor-1，SDF-1)表达水平与缺血性脑卒中(cerebral ischemic stroke, CIS)患者行颈动脉支架成形术(carotidartery stenting，CAS)后支架内再狭窄(in-stent restenosis，ISR)的关系。方法 选取廊坊市人民医院2019 年6 月～ 2021年1 月成功行CAS 的158 例缺血性脑卒中患者，收集患者临床资料，检测患者CAS 术前血清CCR5 和SDF-1 信使核糖核酸(messenger RNA，mRNA)表达水平，根据CAS 后一年有无ISR 将患者分为ISR 组(n=30)和非ISR 组(n=128)。比较ISR 组和非ISR 组临床资料、血清CCR5 和SDF-1 mRNA 表达水平；分析血清CCR5，SDF-1 mRNA 表达水平与管腔直径缩小率的相关性、缺血性脑卒中患者CAS 后发生ISR 的影响因素、血清CCR5，SDF-1 mRNA 表达水平对缺血性脑卒中患者CAS 后发生ISR 的预测价值。结果 ISR 组糖尿病比例(63.33% )、低密度脂蛋白胆固醇(lowdensity lipoprotein-cholesterol，LDL-C)水平(2.57±0.46 mmol/L)、血清CCR5(1.24±0.22)和SDF-1 mRNA(1.32±0.22)表达水平高于非ISR 组(42.97%，2.15±0.34 mmol/L，0.97±0.15，1.00±0.12)，差异均有统计学意义(χ2=4.048，t=5.668，8.233，10.786，均P ＜ 0.05)；血清CCR5 和SDF-1 mRNA 表达水平均与术后一年管腔直径缩小率呈正相关(r=0.516，0.583，P=0.014，0.008)；糖尿病、CCR5 和SDF-1 mRNA 是影响缺血性脑卒中患者行CAS 后发生ISR 的危险因素(Waldχ2=7.057，5.702，6.265，P=0.008，0.017，0.012)；血清CCR5 和SDF-1 mRNA 二者联合预测缺血性脑卒中患者CAS 后发生ISR 的曲线下面积分别为0.848，0.912，0.956；二者联合优于血清CCR5 和SDF-1 mRNA 单独预测(Z=2.192，2.494，P=0.028，0.013)。结论 术前血清CCR5 和SDF-1 mRNA 表达水平与缺血性脑卒中患者CAS后ISR 的发生密切相关，二者对ISR 的发生具有一定的预测效能。
Abstract:
Objective To analyze the relationship between the expression levels of preoperative serum chemokine receptor 5 (CCR5), stromal cell-derived factor-1 (SDF-1) and in-stent restenosis (ISR) after carotid artery stenting (CAS) in patients with cerebral ischemic stroke (CIS). Methods 158 patients with cerebral ischemic stroke who successfully underwent CAS in Langfang People’s Hospital from June 2019 to January 2021 were selected. The clinical data were collected, the expression levels of serum CCR5 and SDF-1 messenger RNA (mRNA) were detected before CAS. According to the presence or absence of ISR one year after CAS, the patients were divided into ISR group (n=30 ) and non ISR group (n=128 ). The clinical data, the expression levels of serum CCR5 and SDF-1 mRNA in ISR group and non ISR group were compared. The correlation between the expression levels of serum CCR5 and SDF-1 mRNA and the reduction rate of lumen diameter, the influencing factors of ISR after CAS in patients with cerebral ischemic stroke, and the predictive value of the expression levels of serum CCR5 and SDF-1 mRNA for ISR after CAS in patients with cerebral ischemic stroke were analyzed. Results The proportion of diabetes (63.33%), LDL-C levels (2.57±0.46 mmol/L), serum CCR5 (1.24±0.22 ) and SDF-1 mRNA (1.32±0.22 ) expression levels in ISR group were higher than those in non ISR group (42.97%，2.15±0.34 mmol/L，0.97±0.15，1.00±0.12)，the differences were statistically significant(χ2=4.048，t=5.668，8.233，10.786，all P ＜ 0.05). The expression levels of serum CCR5 and SDF-1 mRNA were positively correlated with the reduction rate of lumen diameter one year after operation (r=0.516, 0.583, P=0.014, 0.008). Diabetes mellitus, CCR5, SDF-1 mRNA was a risk factor for ISR after CAS in patients with cerebral ischemic stroke (Waldχ2=7.057, 5.702, 6.265，P=0.008, 0.017, 0.012).The areas under curve of serum CCR5, SDF-1 mRNA and their combination in predicting ISR after CAS in patients with cerebral ischemic stroke were 0.848, 0.912 and 0.956 respectively, and the combination of the two was better than the prediction of serum CCR5 and SDF-1 mRNA alone (Z=2.192, 2.494, P=0.028, 0.013). Conclusion The expression levels of serum CCR5 and SDF-1 mRNA before operation were closely related to the occurrence of ISR after CAS in patients with cerebral ischemic stroke, and they have a certain predictive effect on the occurrence of ISR.

参考文献/References:

[1] FATHY N, KORTAM M A, SHAKER O G, et al. Long noncoding RNAs MALAT1 and ANRIL gene variants and the risk of cerebral ischemic stroke: an association study[J]. ACS Chemical Neuroscience, 2021, 12(8): 1351-1362.
[2] DIANA F, DI GREGORIO M, FRAUENFELDER G, et al. Watershed subarachnoid hemorrhage after middle cerebral artery rescue stenting in patients with acute ischemic stroke[J]. Neuroradiology, 2021, 63(8): 1383-1388.
[3] PING Suning, QIU Xuecheng, KYLE M, et al. Brain-derived CCR5 contributes to neuroprotection and brain repair after experimental stroke[J]. Aging and Disease, 2021, 12(1): 72-92.
[4] GAO Jiahui, HE Linhao, YU Xiaohua, et al. CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-catenin(T120)/ TCF21 pathway[J]. Journal of Lipid Research, 2019, 60(12): 2020-2033.
[5] 张燕楠 , 彭云 , 黎艾 , 等．脑梗死患者外周血 SDF-1/CXCR7表达水平与颈总动脉内膜中层厚度及斑块积分的相关性分析 [J]．卒中与神经疾病 , 2021, 28(3): 295-299． ZHANG Yannan, PENG Yun, LI Ai, et al. The correlations between serum SDF-1/CXCR7 and the intima-media thickness and plaque score of the common carotid artery in patients with cerebral infarction [J]. Stroke and Nervous Diseases, 2021, 28(3):295-299.
[6] 中华医学会神经病学分会 .中华医学会神经病学分会脑血管病学组 .中国急性缺血性脑卒中诊治指南 2018[J].中华神经科杂志 , 2018, 51(9): 666-682. Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018 [J]. Chinese Journal of Neurology, 2018, 51(9):666-682.
[7] 高峰 , 杜彬 , 秦海强 , 等．2007年颈动脉支架成形术专家共识 [J].中国卒中杂志 , 2007, 2(5): 430-454. GAO Feng, DU Bin, QIN Haiqiang, et al. 2007 clinical expert consensus document on carotid stenting [J]. Chinese Journal of Stroke, 2007, 2(5):430-454.
[8] GAO Jianfei, QIAN Tingting, WANG Wei. CTRP3 activates the AMPK/SIRT1-PGC-1α pathway to protect mitochondrial biogenesis and functions in cerebral ischemic stroke[J]. Neurochemical Research, 2020, 45(12): 3045-3058.
[9] HURD M D, GOEL I, SAKAI Y, et al. Current status of ischemic stroke treatment: From thrombolysis to potential regenerative medicine[J]. Regenerative Therapy, 2021, 18(1): 408-417.
[10] STILO F, MONTELIONE N, CALANDRELLI R, et al. The management of carotid restenosis: a comprehensive review[J]. Annals of Translational Medicine, 2020, 8(19): 1272.
[11] 李中中 , 苏旭东 , 刘琳 , 等 .颈动脉支架置入术后支架内再狭窄研究进展 [J].中国脑血管病杂志 , 2021, 18(10): 733-736, 封 3. LI Zhongzhong, SU Xudong, LIU Lin, et al. Research progress of restenosis after carotid stenting [J]. Chinese Journal of Cerebrovascular Diseases, 2021, 18(10):733-737, F3.
[12] XUE Hang, LIU Jianpeng, SHI Lin, et al. Overex-pressed microRNA-539-5p inhibits inflammatory re-sponse of neurons to impede the progression of cerebral ischemic injury by histone deacetylase 1[J]. American Journal of Physiology-Cell Physiology, 2020, 319(2): C381-C391.
[13] YAN Jun, XU Weilin, LENAHAN C, et al. CCR5 activation promotes NLRP1-dependent neuronal pyroptosis via CCR5/PKA/CREB pathway after intracerebral hemorrhage[J]. Stroke, 2021, 52(12): 4021-4032.
[14] CHUANG Lipang, CHEN N H, LIN S W, et al. Monocytic C-C chemokine receptor 5 expression increases in in vitro intermittent hypoxia condition and in severe obstructive sleep apnea patients[J]. Sleep & Breathing, 2019, 23(4): 1177-1186.
[15] ZHANG Zhongwen, WANG Qiannan, YAO Jinming, et al. Chemokine receptor 5, a Double-Edged sword in metabolic syndrome and cardiovascular disease[J]. Frontiers in Pharmacology, 2020, 11(1): 146.
[16] 陈增光 , 纪元 , 陈新 , 等 .外周血 CD4+T细胞亚群中趋化性细胞因子受体 5的表达水平与颈动脉狭窄的相关性研究 [J].实用临床医药杂志 , 2019, 23(24): 24-26, 30. CHEN Zengguang, JI Yuan, CHEN Xin, et al. Correlation between expression levels of chemokine cytokine receptor 5 in CD4+ T cell subsets in peripheral blood and carotid stenosis [J]. Journal of Clinical Medicine in Practice, 2019, 23(24):24-26, 30.
[17] 何宏媛 , 楚世峰 , 陈乃宏 .CCR5在神经系统疾病中作用的研究进展 [J].中国药理学通报 , 2021, 37(6): 760-764. HE Hongyuan, CHU Shifeng, CHEN Naihong, et al. Research progress of CCR5 in nervous system diseases [J]. Chinese Pharmacological Bulletin, 2021, 37(6):760-764.
[18] 李亚 , 熊洁 .实验性牙周炎大鼠牙周组织中趋化因子受体 CCR5，CXCL12，RANTES表达及意义 [J].临床口腔医学杂志 , 2022, 38(4): 207-211. LI Ya, XIONG Jie. The expression of chemokines CCR5,CXCL12 and RANTES in the periodontal tissues of experimental periodontitis rats and its significance [J]. Journal of Clinical Stomatology, 2022, 38(4):207-211.
[19] LALOS A, T?LEK A, TOSTI N, et al. Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression[J]. Scientific Reports, 2021, 11(1): 775.
[20] KONTOS C, EL BOUNKARI O, KRAMMER C, et al. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting[J]. Nature Communications, 2020, 11(1): 5981.
[21] 高靖 , 王秀艳 , 杨红梅 , 等 .急性缺血性脑卒中患者血清 SDF-1，UCH-L1水平变化及其与病情程度和预后的关系 [J].山东医药 , 2021, 61(25):46-48. GAO Jing, WANG Xiuyan, YANG Hongmei, et al. Changes of serum SDF-1 and UCH-L1 levels in patients with acute ischemic stroke and their relationship with disease severity and prognosis[J]. Shandong Medical Journal, 2021, 61(25):46-48.
[22] 欧鲤娴 , 孙清己 , 侯俊霞 , 等 .脑梗死患者血清 sdLDL, GSH-Px, Hcy及 SDF-1水平与血管狭窄的相关性研究 [J].现代检验医学杂志 , 2021, 36(6):83-86, 110. OU Lixian, SUN Qingji, HOU Junxia, et al. Study on the correlation between serum sdLDL, GSH-Px, Hcy and SDF-1 levels and vascular stenosis in patients with cerebral infarction [J]. Journal of Modern Laboratory Medicine, 2021, 36(6):83-86, 110.

相似文献/References:

[1]马 炜,朱 俊,徐 健,等.NLR与缺血性脑卒中患者预后关系研究[J].现代检验医学杂志,2016,31(04):139.[doi:10.3969/j.issn.1671-7414.2016.04.043]
　MA Wei,ZHU Jun,XU Jian,et al.Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis for Acute Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2016,31(06):139.[doi:10.3969/j.issn.1671-7414.2016.04.043]
[2]邓 凯,许 薇,李 燕.缺血性脑卒中患者血浆vWF:Ag和S100B检测的临床意义[J].现代检验医学杂志,2017,32(05):52.[doi:10.3969/j.issn.1671-7414.2017.05.014]
　DENG Kai,XU Wei,LI Yan.Clinical Application of Detection of Plasma vWF:Ag and S100B in Ischemic Cerebral Apoplexy Disease[J].Journal of Modern Laboratory Medicine,2017,32(06):52.[doi:10.3969/j.issn.1671-7414.2017.05.014]
[3]张 艳a,刘 翔a,李鸿钏a,等.血清脂蛋白磷脂酶A2 和血浆抗凝血酶Ⅲ对2 型糖尿病患者发生缺血性脑卒中风险的评估价值[J].现代检验医学杂志,2020,35(04):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
　ZHANG Yana,LIU Xianga,LI Hong-chuana,et al.Evaluation Value of Serum Lipoprotein-Associated Phospholipase A2 and Plasma Antithrombin Ⅲ on the Risk of Ischemic Stroke in Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(06):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
[4]利荣乔.血清Galectin-3和HDL-C水平检测对急性缺血性脑卒中预后的影响研究[J].现代检验医学杂志,2021,36(05):128.[doi:10.3969/j.issn.1671-7414.2021.05.029]
　LI Rong-qiao.Effect of Serum Galectin-3 and HDL-C Levels on Prognosis of AcuteIschemic Stroke[J].Journal of Modern Laboratory Medicine,2021,36(06):128.[doi:10.3969/j.issn.1671-7414.2021.05.029]
[5]杜龙庭,勿坡巫且,许春梅,等.缺血性脑卒中患者血清miR-155和PDCD4mRNA表达水平与颈动脉支架成形术后再狭窄的相关性研究[J].现代检验医学杂志,2022,37(02):105.[doi:10.3969/j.issn.1671-7414.2022.02.022]
　DU Long-ting,WUPO Wu-qie,XU Chun-mei,et al.Correlation between the Expression of miR-155, PDCD4 mRNA and Restenosis after Carotid Artery Stenting in Patients with Cerebral Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2022,37(06):105.[doi:10.3969/j.issn.1671-7414.2022.02.022]
[6]阎冬梅,庞文艳,赵莲蕊.慢加急性肝衰竭患者血清Clusterin 和CCR5 表达水平及其对预后预测价值研究[J].现代检验医学杂志,2023,38(03):134.[doi:10.3969/j.issn.1671-7414.2023.03.024]
　YAN Dong-mei,PANG Wen-yan,ZHAO Lian-rui.Predictive Value of Combined Detection of Serum Clusterin and CCR5 Levels for Prognosis of Patients with Acute-on-Chronic Liver Failure[J].Journal of Modern Laboratory Medicine,2023,38(06):134.[doi:10.3969/j.issn.1671-7414.2023.03.024]
[7]王桂瑜,欧阳葵,苏小田,等.缺血性脑卒中患者血清LncRNA MEG8 表达水平及临床价值研究[J].现代检验医学杂志,2023,38(04):105.[doi:10.3969/j.issn.1671-7414.2023.04.019]
　WANG Guiyu,OUYANG Kui,SU Xiaotian,et al.Expression Level of Serum LncRNA MEG8 and Its Clinical Significance in Patients with Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2023,38(06):105.[doi:10.3969/j.issn.1671-7414.2023.04.019]
[8]高继英a,石代乐b,王 刚c.缺血性脑卒中患者血清LncRNA SNHG8 的表达及临床意义[J].现代检验医学杂志,2023,38(05):75.[doi:10.3969/j.issn.1671-7414.2023.05.014]
　GAO Jiyinga,SHI Daileb,WANG Gangc.Expression and Clinical Significance of Serum LncRNA SNHG8 in Patients with Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2023,38(06):75.[doi:10.3969/j.issn.1671-7414.2023.05.014]

备注/Memo

备注/Memo:
基金项目：河北省医学科学研究课题计划项目(编号20201306)；廊坊市科技支撑计划项目(编号2020013074)。
作者简介：何涛(1981-)，男，本科，主治医师，研究方向：脑血管病神经介入， E-mail：hetaotao5723@163.com。
更新日期/Last Update: 2022-11-15